Greater dose-ranging effects on A1C levels than on glucosuria with LX4211, a dual inhibitor of SGLT1 and SGLT2, in patients with type 2 diabetes on metformin monotherapy (Q37461695)
Jump to navigation
Jump to search
scientific article published on 11 September 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Greater dose-ranging effects on A1C levels than on glucosuria with LX4211, a dual inhibitor of SGLT1 and SGLT2, in patients with type 2 diabetes on metformin monotherapy |
scientific article published on 11 September 2014 |
Statements
1 reference
Greater dose-ranging effects on A1C levels than on glucosuria with LX4211, a dual inhibitor of SGLT1 and SGLT2, in patients with type 2 diabetes on metformin monotherapy (English)
1 reference
Julio Rosenstock
1 reference
William T Cefalu
1 reference
Pablo Lapuerta
1 reference
Brian Zambrowicz
1 reference
Ike Ogbaa
1 reference
Phillip Banks
1 reference
Arthur Sands
1 reference
11 September 2014
1 reference
1 reference
1 reference
Identifiers
1 reference